The $90m venture financing of Hyperfine Research was the medical devices industry’s top cross border venture financing deal as total deals worth $352.63m were announced globally in February 2021, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 9.7% over the previous month of $390.33m and a drop of 17.5% when compared with the last 12-month average, which stood at $427.37m.
Comparing cross border venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $250.8m. At the country level, the US topped the list in terms of deal value at $236.8m.
In terms of volumes, Europe emerged as the top region for medical devices industry cross border venture financing deals globally, followed by North America and then Middle East and Africa.
The top country in terms of cross border venture financing deals activity in February 2021 was the US with seven deals, followed by the UK with three and France with three.
In 2021, as of February, medical devices cross border venture financing deals worth $742.96m were announced globally, marking a decrease of 3.4% year on year.
medical devices industry cross border venture financing deals in February 2021: Top deals
The top five medical devices industry cross border venture financing deals accounted for 70.8% of the overall value during February 2021.
The combined value of the top five medical devices cross border venture financing deals stood at $249.77m, against the overall value of $352.63m recorded for the month.
The top five medical devices industry cross border venture financing deals of February 2021 tracked by GlobalData were:
1) Altium Capital, Axiom Associates, Colle Capital Partners, GV Management Co, Huamin Investment Management and Nextrans’ $90m venture financing of Hyperfine Research
2) The $68m venture financing of Syapse by Ally Bridge Group and Northpond Ventures
3) Orbimed Advisors and WuXi Huiying Investment’ $40m venture financing of Guangzhou Benchmark Medical
4) The $30m venture financing of MediSafe Project by 7wireVentures, ALIVE Israel HealthTech Fund, Consensus Business Group, Leumi Partners, Lool Ventures, M Ventures, Menora Mivtachim Holdings, Octopus Ventures, OurCrowd, Pitango HealthTech, Qualcomm Ventures, Sanofi Ventures and TriVentures
5) Andera Partners, Asabys Partners, Caixa Capital Risc SGEIC, Center for the Development of Industrial Technology, Innogest Capital II and VI Partners’ venture financing of Medlumics for $21.77m.